U.S. Federal Judge Grants Alvotech’s Motion to Dismiss AbbVie’s lawsuit alleging misappropriation of trade secrets

Alvotech beats back Abbvie's trade secrets lawsuit

Alvotech Provides Update on FDA Action Regarding AVT02, Proposed High-Concentration Biosimilar to Humira® (adalimumab)

Alvotech Welcomes Positive CHMP Opinion for AVT02, a Proposed Biosimilar to Humira®

The Future of Innovation. Alvotech and the University of Iceland hosted a conference on how academia and industry can create value together

Alvotech Announces Positive Top-line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®

Alvotech initiates clinical studies for AVT04, a proposed biosimilar to Stelara® (ustekinumab)

Alvotech, in collaboration with the University of Iceland, has designed a training program for those who have recently graduated from the fields of biology, chemistry, biochemistry and pharmacology. The program is designed to train individuals to work in the biotech industry.

Create your own future - Is your future in biosimilars?

Alvotech bondholders convert more than $100m at pre-money valuation of $2.7bn

Alvotech reaches primary completion date in its switching study for AVT02, a proposed interchangeable biosimilar to AbbVie's Humira®

Róbert Wessman, Chairman of Alvotech, presented at the Jefferies Global Healthcare Conference, that took place in virtual format on June 1-4, 2021.

Robert Wessman presented at the Jefferies Global Healthcare Conference

Alvotech employees donate to UNICEF Covid relief in India

Alvotech seeks to end AbbVie’s wrongful monopoly on Humira and bring affordable arthritis treatment to U.S.

Alvotech proud sponsor of Reykjavik’s football club KR

Alvotech strongly disputes AbbVie’s allegations of wrongdoing relating to AVT02, Alvotech’s proposed biosimilar to HUMIRA® (adalimumab).

Alvotech disputes AbbVie’s allegations of wrongdoing

Alvotech has successfully completed a second round of its US$ 100 million private placement, for US$ 35 million.

Alvotech completes second round of a US$ 100m private placement

Alvotech and sister company Alvogen donate 100 thousand US dollars to UNICEF

Cipla Gulf and Alvotech today announced that they are expanding their partnership for the marketing and distribution of four biosimilar medicines in Australia and New Zealand.

Cipla Gulf and Alvotech expand partnership for commercialization of biosimilars in Australia and New Zealand

The Equal pay certification follows a rigorous process requiring specific policies, processes and controls to be implemented.

Alvotech Iceland receives Equal Pay Certification

A ground-breaking ceremony for the extension of Alvotech's high-tech centre in Reykjavík took place today. Robert Wessman, Chairman of the Board, Dagur B. Eggertsson, Mayor of Reykjavik and Jon Atli Benediktsson, Rector of the University of Iceland, took the first shoveling together with key employees who have been involved in the project.

Company news